Holiday Sale — Get 40% off Vantage for yourself or as a gift

Published 10 hours ago • loading... • Updated 7 hours ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Summary by Enid News & Eagle

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated…

5 Articles

5 Articles

XTL Biopharmaceuticals receives Nasdaq bid price deficiency notice (NASDAQ:XTLB)

XTL Biopharmaceuticals faces Nasdaq delisting risk over $1 bid price. Learn what this means for XTLB investors and next steps for compliance.

9 hours ago·United States

Read Full Article

+3 Reposted by 3 other sources

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated…

10 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources5

Leaning Left1Leaning Right1Center1Last Updated6 hours agoBias Distribution

34% Left, 33% Center, 33% Right

Bias Distribution

34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right

34% Left

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in 10 hours ago on Wednesday, December 24, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics